is Perindoprilat optional? [Regulatives / Guidelines]

posted by mittyri – Russia, 2018-05-17 22:47 (927 d 01:39 ago) – Posting: # 18779
Views: 2,690

Dear All,

could you please enlighten me what is the reason to analyse and describe PK of Perindoprilat when one of APIs is Perindopril (as an example)?
As EMA stated
Also for inactive prodrugs, demonstration of bioequivalence for parent compound is recommended.
The active metabolite does not need to be measured.


What is the reason why the experts could insist to include Perindoprilat to the list of analytes?

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,220 posts in 4,427 threads, 1,481 registered users;
online 13 (0 registered, 13 guests [including 12 identified bots]).
Forum time: Sunday 23:26 CET (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5